Two Nigerian-made anti-COVID-19 vaccines are currently awaiting clinical trials and eventual certification for use, the Presidential Task Force (PTF) on COVID-19 announced Monday.
Chairman of the PTF and Secretary to the Government of the Federation SGF, Mr. Boss Mustapha, who announced this during the task force’s media briefing in Abuja, also announced the donation of 300,000 doses of Oxford-AstraZeneca vaccines to Nigeria by telecommunications giant, MTN.
- Leah Sharibu gives birth to second baby in Boko Haram captivity
- COVID-19: Nigeria confirms 131 new cases, 102 recoveries
He described the discovery of the potential local vaccines as a welcomed development, which would encourage more of such scientific ventures in the country, and charged all agencies involved in actualising the process to lend all required aids.
“The disclosure that Nigerian scientists have produced at least two local COVID-19 vaccines, which are awaiting clinical trials and certification is significant. This is a welcome development that will open a new vista in scientific breakthrough and will boost the morale and image of the medical industry in the country.
“I call on all relevant agencies to provide the required support and enabling environment for smooth conduct of the remaining protocols for the certification of these vaccines with a view to encouraging and motivating other researchers,” he said.
